Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level

GS
HCPCS Modifier Code

2023 HCPCS Modifiers
Billable/Valid Code

GS is a valid 2023 HCPCS Modifier that could be used to indicate Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level.

GS Modifier has been in effect since Jan 01, 2013.

Short description for GS HCPCS Modifier code:

Epo/darbepoietin reduced 25%

HCPCS GS MODIFIER

GS Modifier information

Modifier:	GS
Description:	DOSAGE OF ERYTHROPOIETIN STIMULATING AGENT HAS BEEN REDUCED AND MAINTAINED IN RESPONSE TO HEMATOCRIT OR HEMOGLOBIN LEVEL
Effective Date:	Jan 01, 2013
Added Date:	Jan 01, 2006
Coverage code:	`D` - SPECIAL COVERAGE INSTRUCTIONS APPLY
Action code:	`N` - NO MAINTENANCE FOR THIS CODE